Week 543 Review - Jubilee Metals gives a very happy end to 2025 and start of 2026.

It was looking like a brilliant week, with nearly everything in the black, until Friday when nearly everything went into the red. However, a socking great rise in JLP:Jubilee Metals meant the deficit between cost and value narrowed by £4,225 to £140,941 and the deficit between injection and value reduced to £58,997, with total portfolio value increasing to £120,871.

Worst performer was EDV:Endeavour Mining which dropped 7% despite gold hardly dropping at all. These are barely in profit, which is a worry if gold has peaked. I'm hoping they will announce big profits and start paying a dividend, which should lead to a re-rate.

TLOU:Tlou Energy dropped 6% but there's nothing unusual in that.

ALU:Alumasc Group has been dropping quite badly over the last few months, but recovered 6% this week to go 25% up.

YU.:Yu Group also rose 6% and are almost in profit.

IES:Invinity Energy announced some new contracts and went up 8%, so my recent purchase is only 10% down but my main holding is 89% down.

AMRQ:Amaroq went up a healthy 10% to go 27% up, but I'm getting increasingly nervous about the intentions of America towards Greenland, and I'm not sure I'm prepared to risk the same fate as POLY:Polymetal and FXP:Ferrexpo which lost almost everything when Putin invaded Ukraine, as I can see similar happening to AMRQ. I might sell the ones in my SIPP but keep the ones in my ISA because they have massive potential if Greenland is left alone.

JLP:Jubilee Metals announced the completion of the sale of South African assets, which was a relief as I was concerned something would mess that up. However now they are certain of the cash, I'm hoping it won't be long before announcements of new tailings purchases. My holdings are still around 50% down, so a long way to break even.

Share of the week is SBTX:SkinBioTherapeutics which went up 18%. I think the recent drops were caused by some big sellers, so hopefully now they have gone, potential investors are considering the potential of the new compound going into products and revenue coming in.

Here's the ISA and shares portfolio after week 23 of year 11.

			Weekly Change
Cash	£99.03		-£78.09
Portfolio cost	£116,875.69		+£117.60
Portfolio sell value (bid price-commission)	£37,547.76	(-67.9%)	+£2,991.04
Potential profits	£390.23		+£150.78
Yr 11 Dividends	£69.36		+£0
Yr 11 Interest	£0.76		+£0.01
Yr 11 Profit from sales	£527.06		+£39.50
Yr 11 proj avg monthly profit	£105.06	(1.4%)	+£3.01
Total Dividends	£12,557.43		+£0
Total Interest	£9.33		+£0.01
Total Profit from sales	£18,087.33		+£39.50
Average monthly cash profit	£239.80	(3.3%)	-£0.12
(Sold stocks profit + Dividends - Fees / Months)

I looked at the price of CWR:Ceres Power and noticed it had dropped back below the price I bought it before selling for a profit. It appears to have been the victim of a bear attack from someone presumably shorting the shares. They've engineered a 50% drop in price, so I think now would be a good time to buy back. 

I sacrificed my holding in BOKU:Boku as it wasn't really going anywhere. I may buy back if I make any profits elsewhere, but I thought there was a better potential in CWR. I sold my 495 shares in BOKU at 212p making £39.50 (3.9%) profit. Not a lot, but still a profit. I bought 538 shares in CWR at 206.681p costing £1,122.50. Happy to say they were up 3% on my purchase price and £19 in profit by the end of the week.

Value was up by almost £3,000 thanks to the big rises in JLP:Jubilee Metals and SBTX:SkinBioTherapeutics, and potential profits rose £150 mainly thanks to AMRQ:Amaroq.

The first time in a very, very long time we've had a good size tick upwards in one week.

Soaring above the trend line

Too small a profit to make any difference.

The SIPP looks like this after week 527 overall and week 7 of year 11.

			Weekly Change
Cash	£1,034.82		+£36.19
Portfolio cost	£143,804.05		+£0
Portfolio sell value (bid price - commission)	£82,190.26	(-42.8%)	+£1,234.65
Potential profits	£11,869.76		+£218.91
Yr 11 Dividends	£309.15		+£36.05
Yr 11 Interest	£0.14		+£0.14
Yr 11 Profit from sales	£800.74		+£0
Yr 11 proj avg monthly profit	£674.70	(8.7%)	-£86.31
Total Dividends	£18,529.35		+£36.05
Total Interest	£20.84		+£0.14
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£348.44	(4.5%)	-£0.37

I had a £36 dividend from INVP:Investec, a more modest increase in value due to smaller holdings in JLP:Jubilee Metals and SBTX:SkinBioTherapeutics, and a decent increase in potential profits of £218 mainly thanks to ALU:Alumasc Group and AMRQ:Amaroq.

I like that graceful glide up towards the injection line.

Nicely above the trend line, but is it just a short-lived Santa Rally?

We're on the trend line. Selling my SIPP AMRQ:Amaroq should keep me above it next week.

I think I'm pretty much decided on selling my SIPP holding in AMRQ:Amaroq. It doesn't qualify as a SIPP holding because it doesn't pay dividends and isn't on my magic formula ranking. Selling at Friday's close price will get me £288 (17%) profit and liberate £1,929. It's in my Hargreaves Lansdown account, which is about to get £2,400 transfer from my pension and has £300 cash, so I'll have around £4,700 to invest in one go.

It's a shame HL doesn't allow regular investments from cash balance - it only allows them via direct debit, with the new injection invested each month. AJ Bell is much better as you can set up regular investments on the cash balance. When I sell an AJ Bell share, I leave it as cash so the regular investments have a pot to use.

I should really re-invest at least some of the proceeds in gold stocks, but there are few suitable candidates. CMCL:Caledonia Mining are 115th in my magic formula ranking and have always done badly for me. They are racking up big debt for a new mine and having to sell a load of gold using Zimbabwe currency so there are too many red flags. EDV:Endeavour Mining are 138th in my magic formula ranking, but they are massively increasing both production and free cash flow, reducing debt rapidly and paying dividends, so given my holding is only up 2% due to a recent pull-back, maybe I should put all AMRQ:Amaroq proceeds there.

Meanwhile I'll continue with my original plan to invest £1,100 in both HSX:Hiscox and MGNS:Morgan Sindall, and use the rest to increase my holding in BPM:BP Marsh & Partners. It's nice to have a plan!

Week 542 Review - A good week for Christmas

A nice positive week for Christmas. Very little happened, but most of it was positive. The deficit between cost and value narrowed by £1,204 to £145,167, and the deficit between injection and value decreased to £63,357. Total portfolio value went up to £116,511.

Only big loser was PBX:Probiotix Health which dropped 0.5p which is 7%. A continued drift downwards after spiking briefly a few months ago.

SBTX:SkinBioTherapeutics recovered from recent drops to go up 8% but is still a long way down.

Share of the Week is PAF:Pan African Resources, which also climbed 8% but has now gone 296% up. My biggest ever profit margin for a share. I slightly regret taking some profits, but I did it to spread my gold risk to some other holdings, most of which are also doing well. I don't want to sell any more.

Here's the ISA and shares portfolio after week 22 of year 11.

			Weekly Change
Cash	£177.12		+£50.00
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£34,439.12	(-70.5%)	+£110.18
Potential profits	£239.45		+£46.47
Yr 11 Dividends	£69.36		+£0
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£102.05	(1.4%)	-£4.86
Total Dividends	£12,557.43		+£0
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£239.92	(3.3%)	-£0.45
(Sold stocks profit + Dividends - Fees / Months)

The rise in SBTX:SkinBioTherapeutics countered the drop in PBX:Probiotix Health and all three profitable shares went up a little, but most things remained flat, so very little change in value. Cash went up £50 thanks to an injection to my share account to cover fees.

Flat.

Still pretty much on the trend line.

The SIPP looks like this after week 526 overall and week 6 of year 11.

			Weekly Change
Cash	£998.63		+£121.50
Portfolio cost	£143,804.05		+£0
Portfolio sell value (bid price - commission)	£80,955.61	(-43.7%)	+£1,094.74
Potential profits	£11,650.85		+£1,170.97
Yr 11 Dividends	£273.10		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£\800.74		-£0
Yr 11 proj avg monthly profit	£913.22	(9.9%)	-£152.21
Total Dividends	£18,493.30		+£0
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£348.81	(4.5%)	-£0.66

Cash went up £121 thanks to tax rebates, and most magic formula shares went up so both value and potential profits went up by just over £1,000. Nothing else happened.

Is it my imagination or is the gap to injection actually narrowing?

A satisfying gap above the trend line.

I guess it was inevitable that the trend line would catch up at some point. It was always going to be difficult to maintain that performance. I don't want to sell good shares to try and maintain the rise. JLP:Jubilee Metals could fix that if they just sort themselves out.

I've transferred £2,300 out of my work pension into my SIPP which should arrive either next week or more likely the week after. Currently I'm planning on buying HSX:Hiscox and MGNS:Morgan Sindall to add to my magic formula collection, unless either spikes before then.

Week 541 Review - Great week for the SIPP, flat for the ISA.

A good week for my SIPP, and a flat week for my ISA. A mini Santa Rally saw the deficit between cost and value narrow by £1,299 to £146,372 and the deficit between injection and value reduce to £64,625. Total portfolio value increased to £115,194.

Worst performer was AFC:AFC Energy which dropped 9%, which I suspect was profit taking after the recent big rise. Unfortunately my holding is now back to 32% down making a £667 loss.

TRU:Trufin dropped 5% for no clear reason and my holding is now only 5% up making £48 potential profit.

It was all good news after that.

BOKU:Boku had slid into loss over the last few weeks, but went up 5% and is just in profit by £4.

III:3i Group was a new purchase last week and went up 5% to go 7p into profit. I don't really want them to climb too quickly as I have another 4 months of buying with my monthly investment.

INVP:Investec had slid a bit recently but recovered 5% to go just 3% down making a £37 loss.

IES:Invinity Energy announced some new projects that have been delivered and went up 6%. My recent purchase is down 17% making £52 loss but my old holding is still 90% down making £1,174 loss..

PRU:Prudential has been on a great run and climbed another 7% this week to go 17% up and making £179 potential profit.

RAT:Rathbones also went up 7% and has gone into profit by 3% making £25 potential profit.

EDV:Endeavour Mining had a good week on an increasing gold price, rising 9% and going 8% up and making £96% profit.

Share of the Week is GGP:Greatland Resources which went up 10% and is now 86% up and making £1,059 potential profit.

Here's the ISA and shares portfolio after week 21 of year 11.

			Weekly Change
Cash	£127.12		+£0
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£34,328.94	(-70.6%)	-£83.51
Potential profits	£192.98		-£53.47
Yr 11 Dividends	£69.36		+£0
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£106.91	(1.5%)	-£5.34
Total Dividends	£12,557.43		+£0
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£240.37	(3.3%)	-£0.44
(Sold stocks profit + Dividends - Fees / Months)

Virtually nothing happened. All my big holdings were flat and the £53 drop in potential profits was all TRU:Trufin.

Sticking to that pesky trend line.

The SIPP looks like this after week 525 overall and week 5 of year 11.

			Weekly Change
Cash	£877.13		+£74.23
Portfolio cost	£143,804.05		+£0
Portfolio sell value (bid price - commission)	£79,860.87	(-44.5%)	+£1,382.60
Potential profits	£10,479.88		+£1,043.42
Yr 11 Dividends	£273.10		+£74.23
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£800.74		+£0
Yr 11 proj avg monthly profit	£913.22	(11.8%)	-£147.89
Total Dividends	£18,493.30		+£74.23
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£349.47	(4.5%)	-£0.06

Cash went up £74 thanks to a £32 dividend from N91:Ninety One, £13 from SCT:Softcat and £18 from YU.:Yu Group. Most of the £1,382 rise was in profitable shares, so potential profits increased by £1,043, and having those dividends is helping maintain my long term performance. It would be great to get to a stage where I have enough dividend-paying shares to have 4.5% return without needing to sell anything.

The gap to injection is narrowing. It would be so good to cross that line.

A definite tick up above the trend line.

Still just above the trend line but it's catching up.

Nice to have a positive week just before Christmas. There will be a few trading days next week so lets hope it continues.

Week 540 Review - Record deficit between cost and value a poor Christmas present

A pretty bad week across much of the portfolio, and a new record low. Thankfully some decent rises offset the big drops in some of my key holdings. The deficit between cost and value widened by £584 to a new high of £147,671, and the deficit between injection and value rose to £65,998. Total portfolio value fell to £113,820.

The worst performer was my largest holding OPTI:Optibiotix, which dropped 1p and lost over £2,000  in value, so the fact the weekly drop was only £584 shows how well some other shares did.

SBTX:SkinBioTherapeutics is another of my biggest holdings and dropped 12% probably due to one large shareholder having sold out.

ALU:Alumasc Group dropped 8% for no reason but my holding is still 20% up overall. They have had a pretty massive fall over the last few months, with shareholders worried about increasing costs and potentially smaller profits. I've re-calculated my magic formula rankings based on their recent performance and they drop to 28th, but that's still in the top 50, so I'll only sell if they drop outside that.

AMP:Ampeak Energy dropped 7% for no obvious reason.

FDM:FDM Group continue to slide after I thought they were staging a recovery, but they fell 6% this week to go 60% down.

POLR:Polar Capital were having a great run, but it seems to be over, with a drop of 5% this week leaving my holding only just in the black.

AMRQ:Amaroq released amazing drilling results, but only managed to climb 5%, but that was enough to put my SIPP holding back into profit and my ISA holding is 14% up.

TLOU:Tlou Energy continue to yo-yo and went up 6% this week.

TRU:Trufin climbed 6% and are now 10% up in my ISA.

AFC:AFC Energy continue to surge, with another 7% gain this week leaving my holding only down 26%.

FXPO:Ferrexpo is another yo-yo stock that would be great for trading. They went up 8% this week so my holding is now 85% down.

GGP:Greatland Resources had a splendid week, climbing 13% to go 69% up overall.

Share of the Week is PBX:Probiotix Health which went up 17% and is now 66% down. I suspect that the person selling a big chunk of SBTX:SkinBioTherapeutics may have put it here and caused a short term blip, as there's no sign of longer term price support.

Here's the ISA and shares portfolio after week 20 of year 11.

			Weekly Change
Cash	£127.12		+£40.01
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£34,412.45	(-70.5%)	-£378.99
Potential profits	£246.45		+£128.94
Yr 11 Dividends	£69.36		+£44.04
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£112.25	(1.5%)	+£3.21
Total Dividends	£12,557.43		+£44.04
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£240.81	(3.3%)	-£0.13
(Sold stocks profit + Dividends - Fees / Months)

I got a £44 dividend from ASHM:Ashmore Group minus monthly fees from AJ Bell. Potential profits are up £128 thanks to AMRQ:Amaroq and TRU:Trufin both having good weeks and despite BOKU:Boku sliding to a loss. The drop in portfolio value was pretty small all things considered.

Not the bounce I was hoping for as we lead into Christmas

Staying on the trend line

The SIPP looks like this after week 524 overall and week 4 of year 11.

			Weekly Change
Cash	£802.90		-£547.47
Portfolio cost	£143,804.05		+£707.67
Portfolio sell value (bid price - commission)	£78,478.27	(-45.4%)	-£205.29
Potential profits	£9,436.46		+£525.56
Yr 11 Dividends	£198.87		+£163.67
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£800.74		+£0
Yr 11 proj avg monthly profit	£1,061.11	(13.7%)	-£122.30
Total Dividends	£18,419.07		+£163.67
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£349.53	(4.5%)	+£0.66

I did my monthly investments. First I continued buying RAT:Rathbones. I bought 13 shares at 1821p costing £239.41. Unfortunately they promptly dropped to 1780p so my timing wasn't great. I have one more month of buying RAT.

Next I added to my position in SCT:Softcat as I think the recent drop is unjustified. I bought 17 shares at 1423.9255p costing £244.78. I'll buy more next month if they continue to remain depressed.

Finally I bought back into III:3i Group after their recent share price collapse, as I think it was over-done. It does however mean I was right to sell them when I suspected they were over valued. I bought 7 shares at 3155.497p costing £223.48.

I had an impressive £163 in dividends, made up of £49 from JHD:James Halstead, £12 from KNOS:Kainos Group and £102 from PAF:Pan African Resources.

Potential profits went up by £525 because many profitable shares had a good week, and that reduced the losses from the big fallers to just £205.

The gap to injection has been remarkably constant, but isn't improving.

Fractionally above the trend line

Again just above the trend line.

If there's going to be a Santa rally then it needs to be next week, but I can't see where it's going to come from. I only have enough cash in my SIPP to do one more month of multiple regular investments. I'd love to be able to boost that pot before 10th February else I'll have to go back to just the one monthly purchase from my regular savings.

News came through that my DDDD:4D Pharma shares are officially worthless and they have been cancelled. I was holding out a tiny hope they'd get something for selling the IP, but it at least ends the chapter of my worst ever investment, losing £18,600. That disaster is going to impact my performance for a long time to come, and I know it won't be the last as TRX:Tissue Regenix will be dead very soon, as will KIBO:Kibo Energy, and between them they will lose me £6,000. If OPTI:Optibiotix goes bust then I may as well give up.

Week 539 Review - A down week overall although SIPP up slightly.

A down week due to a big drop in the ISA, although the SIPP was in the black. The deficit between cost and value widened by £483 to £147,087 and the deficit between injection and value widened to £65,614. Total portfolio value dropped to £114,204.

Worst performer was IPX:Impax Asset Management which dropped 14% after final results. I don't understand, as the share price was massively hammered when they lost the St James's Place contract, and the figures were based on no longer having that contract, so they have been hammered twice for the same news. My main holding is now down 67% and my recent purchase is already down 22%.

SBTX:SkinBioTherapeutics results were predictably hopeless and the share price dropped by 11% back to where it was before a recent steady climb.

TLOU:Tlou Energy dropped 10% in the usual massive yo-yo.

BOKU:Boku dropped 8% for no obvious reason and have now slipped to a 2% loss.

PAF:Pan African Resources had a good week, climbing 6% to go 247% up.

GGP:Greatland Resources also had a good week, climbing 8% to go 49% up.

Share of the week is AFC:AFC Energy which climbed 10% and my holding is now only 37% down, which is significantly better than just a few weeks ago. A respected pundit has tipped them as a potential 10-bagger which helped. I hope he's right.

Here's the ISA and shares portfolio after week 19 of year 11.

			Weekly Change
Cash	£87.11		-£3.75
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£34,791.44	(-70.2%)	-£919.49
Potential profits	£117.51		-£81.38
Yr 11 Dividends	£25.32		+£0
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£109.04	(1.5%)	-£6.96
Total Dividends	£12,513.39		+£0
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£240.94	(3.3%)	-£0.47
(Sold stocks profit + Dividends - Fees / Months)

Cash went down due to ISA fees, and big drop in value thanks to JLP:Jubilee Metals and SBTX:SkinBioTherapeutics.  With none of my profitable shares increasing and BOKU:Boku having a big drop, potential profits fell by £81.

The slide continues

Sticking with that trend line

The SIPP looks like this after week 523 overall and week 3 of year 11.

			Weekly Change
Cash	£1,350.37		+£233.34
Portfolio cost	£143,096.38		+£0
Portfolio sell value (bid price - commission)	£77,975.89	(-45.5%)	+£436.00
Potential profits	£8,910.90		+£1,009.88
Yr 11 Dividends	£35.20		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£800.74		+£0
Yr 11 proj avg monthly profit	£1,183.21	(15.3%)	-£627.80
Total Dividends	£18,255.40		+£0
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£348.87	(4.5%)	-£0.80

Cash increased due to the arrival of my £250 monthly investment money, minus monthly SIPP fees. Value increased by £436 despite some big drops, and potential profits went up by over £1,000 thanks to a 4% rise in CAML:Central Asia Metals, 4% for KNOS:Kainos Group and the big rises in GGP:Greatland Resources and PAF:Pan African Resources.

Year 11 projected performance is skewed by last week's sale, so will drop dramatically over the next few weeks. TRX:Tissue Regenix announced they are de-listing and granting an epic number of shares to an existing investor to bail them out, which will make my shares utterly worthless. I'll lose £3,437 which will hammer my year 11 and long term performance, so I really need to sell enough to make £2,600 profit to balance out the loss for year 11. I'm reluctant to lose some of my more profitable shares though, so I may just take the hit for now and hope JLP:Jubilee Metals sorts itself out so I can plug the gap.

Great to see that gap closing, but very slowly.

Just above the trend line.

This is going to be ruined when I recognise the TRX:Tissue Regenix loss.

So, this first week in December has failed to deliver a Santa rally as my portfolio has dropped in value. At the moment I can't see where any rally is going to come from, as my biggest holdings are still drifting downwards. At least CAML:Central Asia Metals is staging a bit of a recovery as that's my 4th biggest holding. RIO:Rio Tinto is my 6th biggest, and that's now in profit and sneaking up too. Unfortunately OPTI:Optibiotix, JLP:Jubilee Metals and PBX:Probiotix Health are my top 3 and they are utterly hopeless, and SBTX:SkinBioTherapeutics is 5th and that is going downwards. 

Week 538 Review - Not a bad week for the SIPP but a drop for the ISA.

A positive week despite a drop in OPTI:Optibiotix and PBX:Probiotix Health. The ISA is more exposed to those than the SIPP so had a negative week, whereas the SIPP finished up despite banking some profits. The deficit between cost and value narrowed by £456 to £146,603 and the deficit between injection and value narrowed to £65,110. Total portfolio value increased to £114,458.

Worst performer was PBX:Probiotix Health which dropped 8% just a week after falling 7%. I fear these are set to languish for some time. OPTI:Optibiotix dropped 4% and between them they caused most of the damage to the ISA.

BEZ:Beazley had a dreadful week, dropping 7% after a trading statement that lowered outlook for the following year. I had suspended buying these in my monthly savings as they had been creeping up, but I may look to add some more as I think the drop is over-done.

They were the only big losers this week.

FXPO:Ferrexpo climbed a massive 29% on renewed hopes for a Ukrainian peace deal, but they are still 85% down so I'm not allowing them anywhere near Share of the Week despite having to report on them again now.

ASHM:Ashmore Group, KNOS:Kainos Group, POLR:Polar Capital and PRU:Prudential all went up 5% in what seemed like a reversal of last week's drop.

PSN:Persimmon and RAT:Rathbones went up 6% for the same reason, as did TLOU:Tlou Energy, but that's more the usual yo-yo of this share.

AFC:AFC Energy went up a healthy 8% given there was no news.

IHP:Integrafin recovered from last week's big drop with a 10% increase which put my holding back into profit.

Share of the Week is PAF:Pan African Resources which also rose 10% despite going ex-dividend and is now 227% up, so I sold a small amount to bank some profit after qualifying for the dividend. I probably shouldn't sell any more.

Here's the ISA and shares portfolio after week 18 of year 11.

			Weekly Change
Cash	£90.86		+£0
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£35,710.93	(-69.4%)	-£335.99
Potential profits	£198.89		+£58.65
Yr 11 Dividends	£25.32		+£0
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£116.00	(1.6%)	-£6.82
Total Dividends	£12,513.39		+£0
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£241.41	(3.3%)	-£0.45
(Sold stocks profit + Dividends - Fees / Months)

Drop in value was mainly due to PBX:Probiotix Health and OPTI:Optibiotix, but potential profits went up £58 thanks to increases in AMRQ:Amaroq, BOKU:Boku and TRU:Trufin, all of which are recent purchases and 2 of which were using my new AIM magic formula. It's just a shame I'll never get to sell the older holdings so I can move them into my new strategy.

Still essentially flat

Still relentlessly following the trend line

Will it ever go up more than that blip?

The SIPP looks like this after week 522 overall and week 2 of year 11.

			Weekly Change
Cash	£1,117.03		+£25.85
Portfolio cost	£143,096.38		+£879.00
Portfolio sell value (bid price - commission)	£77,539.89	(-45.8%)	+£792.67
Potential profits	£7,901.02		+£585.51
Yr 11 Dividends	£35.20		+£25.85
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£800.74		+£800.74
Yr 11 proj avg monthly profit	£1,811.21	(23.5%)	+£1,770.71
Total Dividends	£18,255.40		+£25.85
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£800.74
Average monthly cash profit	£349.67	(4.5%)	+£6.20

I sold 1,200 shares in PAF:Pan African Resources at 99.2114p making £800.75 (212%) profit. I wanted to keep the investment in gold, and after being spooked out of EDV:Endeavour Mining early in the year I decided to buy back in, purchasing 35 shares at 3505.156p costing £1,244.88. I'm hoping they will start paying dividends very shortly, and it spreads the risk a little in case anything happens to PAF.

I got a £25 dividend from UKW:Greencoat UK Wind and potential profits went up £585 despite realising £800 profit. Year 11 projected performance is silly because it's only week 2, whereas long term performance remained at 4.5% and only went up £6 a month. That is over 10 years though.

A teensy tick up

Fractionally above the trend line

More profit keeps me above the trend line.

OPTI:Optibiotix and JLP:Jubilee Metals have both given the news we were waiting for, and the share price has hardly budged, in fact it's dropped slightly for both. Any hopes for a quick resolution to my poor performance have been dashed, at least for now. Thankfully my new strategy is paying off, but it's such a small percentage of my portfolio that while the older shares are languishing, so is my overall performance. 

Week 537 Review - A dreadful week for my SIPP.

A pretty dreadful week for most of the portfolio, with the rare situation where the SIPP accounted for the majority of the week's losses while the ISA was pretty flat. The deficit between cost and value widened by £1,472 to £147,060 and the deficit between injection and value widened to £66,471. Total portfolio value dropped to £113,097.

This week's biggest loser was IPX:Impax Asset Management which dropped a massive 10%. There was no news, so I don't know why there was such a big fall. It meant my recent purchase went from being 1% in profit to 9% in the red, although that's better than my initial purchase which is down by 62%.

INVP:Investec also went from profitable into loss, dropping 9% to go 4% down. This was after a half yearly trading update that wasn't well received.

FDM:FDM Group dropped 8% which could have been profit taking after the big rise last week.

IHP:Integrafin dropped 8% for no obvious reason, making me contemplate buying more.

PBX:Probiotix Health have been drifting for a while on no news and fell 7% this week.

ASHM:Ashmore Group dropped 6% and continue to plummet since the end of October when I thought they may be returning to break even.

AFC:AFC Energy continue to yo-yo and dropped 5% this week, which is less than usual.

N91:Ninety One dropped 5% which was probably reaction to the half-yearly report, but it looked OK to me.

PAF:Pan African Resources dropped 5% as the price of gold fell a little. My holding is still up by 196% though.

POLR:Polar Capital dropped 5% for no reason, which dented my potential profits given I've bought quite a lot recently.

TLOU:Tlou Energy went up by 5%, but it's just the usual weekly ups and downs.

ALU:Alumasc Group got a bit hammered recently but are slowly crawling back, increasing 6% this week.

SBTX:SkinBioTherapeutics has mysteriously risen 10% this week. There are rumours of an imminent product launch so it could be tied in with that, although I've seen no evidence to substantiate the rumours.

AMP:Ampeak Energy went up 12% after confirmation that funding has been received for their battery storage project.

FXPO:Ferrexpo went up 16% which may have been a reaction to the possible Ukraine peace plan. However, now that's been revealed as just a Russian wish-list they will no doubt drop again next week. For now it's taken them to 88% down so below 90% and I have to start reporting on them again.

Share of the week is GAW:Games Workshop which zoomed up 16% after a great trading statement and improved guidance from analysts. My holding went to to 101% up, joining PAF:Pan African Resources as my only shares above 100% up.

Here's the ISA and shares portfolio after week 17 of year 11.

			Weekly Change
Cash	£90.86		+£0.01
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£36,046.92	(-69.1%)	-£90.80
Potential profits	£140.24		-£31.59
Yr 11 Dividends	£25.32		+£0
Yr 11 Interest	£0.75		+£0.01
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£122.82	(1.7%)	-£7.68
Total Dividends	£12,513.39		+£0
Total Interest	£9.32		+£0.01
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£241.86	(3.3%)	-£0.46
(Sold stocks profit + Dividends - Fees / Months)

A virtually flat week as OPTI:Optibiotix increased 4% and SBTX:SkinBioTherapeutics climbed 10% while JLP:Jubilee Metals dropped 3% and PBX:Probiotix Health dropped 7% so the changes evened themselves out, but in the red overall. Potential profits dropped slightly thanks to a 3% fall in AMRQ:Amaroq.

This has been pretty flat for some time now.

Right on the trend line.

The SIPP looks like this after week 521 overall and week 1 of year 11.

			Weekly Change
Cash	£1,091.18		+£63.90
Portfolio cost	£142,217.38		+£0
Portfolio sell value (bid price - commission)	£75,868.22	(-46.7%)	-£1,381.53
Potential profits	£7,315.51		-£512.98
Yr 11 Dividends	£9.35		+£9.35
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£0		+£0
Yr 11 proj avg monthly profit	£40.50	(0.5%)	+£40.50
Total Dividends	£18,229.55		+£9.35
Total Interest	£20.70		+£0
Total Profit from sales	£24,666.51		+£0
Average monthly cash profit	£343.47	(4.5%)	-£0.58

This portfolio was hammered, as it was mainly magic formula shares that took big drops. Potential profit fell £512 mainly due to big drops in AMRQ:Amaroq, N91:Ninety One, PAF:Pan African Resources, POLR:Polar Capital and PRU:Prudential. GAW:Games Workshop clawed some of the losses back else it would have been worse.

Cash went up thanks to a tax rebate and £9 dividends from GAW:Games Workshop, and that means in week 1 of  year 11the projected profit is £40 a month, which I may be able to maintain without sales as more dividends come in.

Although a bad week, this has been fairly flat lately.

This week's drop takes us just below the trend line - again.

Still just above the trend line.

We had the JLP:Jubilee Metals production update and the price dropped, so there is very little hope of a revival any time soon. There is an update on joint venture partners due before the end of November, so still a glimmer of hope of something happening before Christmas, but no guarantee it will be positive.

OPTI:Optibiotix still haven't given the promised 2nd generation products update. There was news of a new Slimbiome contract, but a rather puny 0.3p rise was all we got out of it. This is another one where I fear there is little hope of improvement before Christmas.

The American market reversed declines on Friday after the UK market had closed, which seems to happen quite often on Fridays. Hopefully that increase will be reflected in our market on Monday morning.